This randomized clinical trial examines the association of prostate-specific membrane antigen positron emission tomography (PET)–guided intensification of salvage radiotherapy with failure-free survival among patients with prostate cancer after radical prostatectomy. Here, FOLH1 is linked to prostate cancer.